Three cases of endometrial cancer associated with "bioidentical" hormone replacement therapy

被引：35

作者：

Eden, John A. ^{[1
]}

Hacker, Neville F.

Fortune, Michael

机构：

[1] Univ New S Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia

[2] Royal Hosp Women, Sydney, NSW, Australia

来源：

MEDICAL JOURNAL OF AUSTRALIA | 2007年 / 187卷 / 04期

关键词：

D O I：

10.5694/j.1326-5377.2007.tb01210.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe three women who developed endometrial cancer after taking "bioidentical" hormone replacement therapy (HRT) to relieve menopausal symptoms. Although pharmaceutical HRT is a well established and tested therapy, little is known about the quality control, safety and efficacy of bioidentical HRT Women should be advised to avoid bioidentical HRT, and those who continue to use it should receive regular endometrial surveillance.

引用

页码：244 / 245

页数：2

共 5 条

[1]

*CTR DRUG EV RES, GUID IND ESTR ESTR P

[2] Hormone replacement therapy and endometrial, ovarian and colorectal cancer [J].

Gambacciani, M ;

Monteleone, P ;

Sacco, A ;

Genazzani, AR .

BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 17 (01) :139-147

[3]

*N AM MEN SOC, 2006, P POSTG COURS PRI 17, P11

[4] Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial [J].

Rossouw, JE ;

Anderson, GL ;

Prentice, RL ;

LaCroix, AZ ;

Kooperberg, C ;

Stefanick, ML ;

Jackson, RD ;

Beresford, SAA ;

Howard, BV ;

Johnson, KC ;

Kotchen, JM ;

Ockene, J .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 288 (03) :321-333

[5] Should epidemiology, the media and quangos determine clinical practice? [J].

Sturdee, D ;

MacLennan, A .

CLIMACTERIC, 2004, 7 (01) :1-2

← 1 →